¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"marginal zone lymphoma"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • mantle cell lymphoma
    ¿ÜÅõ¼¼Æ÷¸²ÇÁÁ¾
  • neutral zone
    Ç׿øÇ×üÆòÇü±¸¿ª
  • NK/T cell lymphoma
    NK/T¼¼Æ÷¸²ÇÁÁ¾
  • non-Hodgkin¡¯s lymphoma
    ºñÈ£ÁöŲ¸²ÇÁÁ¾
  • ossification zone
    »ÀµÇ±âÃþ, »À¹ß»ýÃþ, °ñÈ­´ë
  • polar zone
    ºÐ±Ø´ë
  • proliferation zone
    Áõ½ÄÃþ
  • reserve zone
    ¿¹ºñÃþ
  • subcutaneous panniculitis-like T-cell lymphoma
    ÇÇÇÏÁö¹æÃþ¿°À¯»çT¼¼Æ÷¸²ÇÁÁ¾
  • subventricular zone
    ³ú½Ç¹Ø±¸¿ª, ³ú½ÇÇÏ´ë
  • well-differentiated lymphocytic lymphoma
    °íºÐÈ­¸²ÇÁ±¸¸²ÇÁÁ¾
  • zone
    1. ±¸¿ª, ¿µ¿ª 2. ´ë 3. Ãþ
  • zone electrophoresis
    ±¸¿ªÀü±âÀ̵¿
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • high-zone tolerance
    Ç׿ø°ú·®Çã¿ë
  • inhibition zone
    ¾ïÁ¦¿µ¿ª
  • interface zone
    °æ°è¸é¿µ¿ª
  • internal zone
    ¼ÓÃþ
  • low-zone tolerance
    Ç׿ø¼Ò·®Çã¿ë
  • neutral zone
    Ç׿øÇ×üÆòÇü±¸¿ª
  • odontogenic zone
    Ä¡¾Æ¹ß»ýÃþ, Á¶Ä¡Ãþ
  • ossification zone
    »À¹ß»ýÃþ
  • polar zone
    ºÐ±Ø´ë
  • proliferation zone
    Áõ½ÄÃþ
  • radiolucent zone
    ¹æ»ç¼±Åõ°ú¿µ¿ª
  • reserve zone
    ¿¹ºñÃþ
  • root entry zone
    ½Å°æ»Ñ¸®ÁøÀÔºÎ
  • sclerotic zone
    °ø¸·´ë
  • temperate zone strain
    ¿Â´ëÁö¿ªÁÖ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • radiolucent zone
    ¹æ»ç¼± Åõ°ú ¿µ¿ª
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • non hodgkin lymphoma
    ºñÈ£ÁöŲ¸²ÇÁÁ¾(¡­ðþ)
  • non-Hodgkins lymphoma
    ºñÈ£ÁöŲ¸²ÇÁÁ¾
  • non-hodgkins lymphoma
    ¸û¸ù¸û¸²ÇÁÁ¾(¡­ðþ)
  • small lymphocytic lymphoma
    ¼Ò¸²ÇÁ±¸ ¸²ÇÁÁ¾
  • t cell lymphoma
    T ¼¼Æ÷ ¸²ÇÁÁ¾
  • t-cell leukemia/lymphoma
    T¼¼Æ÷¹éÇ÷º´/¸²ÇÁÁ¾
  • acute marginal periodontitis
    ±Þ¼º ¿¬º¯¼º Ä¡ÁÖ¿°(¡­æÞÜ«àõöÍñ²æú).
  • inner marginal epithelium
    ³»¿¬»óÇÇ.
  • lateral marginal vein
    °¡Âʸ𼭸®Á¤¸Æ
  • left marginal branch
    ¿Þ¸ð¼­¸®°¡Áö
  • mandibular marginal branch
    Åθ𼭸®°¡Áö
  • marginal
    ¸ð¼­¸®ÀÇ, ¿¬º¯(æÞÜ«)ÀÇ.
  • marginal abscess
    Ç×¹®º¯¿¬³ó¾ç(Ç×¹®º¯¿¬³ó¾ç).
  • marginal area
    °¡ÀåÀÚ¸®±¸¿ª
  • marginal artery
    ¸ð¼­¸®µ¿¸Æ, ¿¬º¯µ¿¸Æ(æÞÜ« ÔÑØæ).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
AVZ avascular zone
BMZ basement membrane zone
CDZ chlordiazepoxide; conduction delay zone
CFZ capillary free zone
CTZ chemoreceptor trigger zone; chlorothiazide
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
PZ Peripheral zone
PZP Pregnancy Zone Protein
SVZ Subventricular zone
ZPA Zone of Polarizing Activity
ATZ anal transitional zone
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • fibrocartilage zone
    ¼¶À¯ ¿¬°ñ´ë
  • Fraunhofer zone
    ÇÁ¶ó¿îÈ£ÆÛ À½¿ª
  • free zone
    ÀÚÀ¯ ¿µ¿ª, ºó ¿µ¿ª
  • Frenel zone
    ÈÄ·¹³Ú À½¿ª
  • infective zone
    °¨¿°´ë, Àü¿°´ë
    °¨¿°ÀÇ À§Ç輺ÀÌ ÀÖ´Â ºÎÀ§.
  • inhibition zone
    ¾ïÁ¦´ë
    ħ°­ ¶Ç´Â ÀÀÁý ¹ÝÀÀ¿¡¼­ Ç×ü ³óµµ°¡ ³ôÀº Ç÷û¿¡¼­´Â Ç׿ø ÀÔÀÚ¿Í ¹ÝÀÀÀ» ³ªÅ¸³»Áö ¾Ê´Â Çö»ó.
  • intermediate zone
    Áß°£´ë, Áß¾ÓºÎ, °üÀý ¿øÆÇ Áß°£ºÎ
  • junctional zone
    Á¢ÇÕ ºÎÀ§
  • latent zone
    Àẹ´ë
    ¼¼±ÕÀÇ ÀÏ»ý¿¡¼­ Àẹ±â
  • Looser's zone
    Looser Áö¿ª, Looser ´ë
  • mantle zone
    ¿ÜÅõ Ãþ
  • motor zone
    ¿îµ¿´ë
  • nominal hazard zone
    ÁöÁ¤µÈ À§ÇØ Áö¿ª
  • odontogenic zone
    Á¶Ä¡Ãþ
  • opaque zone
    ºÒÅõ¸í Ãþ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
human T-cell lymphoma/leukaemia virus A group of viruses (subfamily Oncovirinae, family Retroviridae) that are lymphotropic with a selective affinity for the helper/inducer cell subset of T lymphocytes and that are associated with adult T-cell leukaemia and lymphoma.
Synonym: human T-cell lymphotropic virus.
(05 Mar 2000)
small bowel lymphoma <radiology> Patterns:, infiltrative dilatation, nodular multiple filling defects, polypoid may cause intussiception from leading point associated with Burkitt lymphoma, endoexoenteric fistulae
(12 Dec 1998)
small lymphocytic lymphoma <tumour> Essentially the same disease as chronic lymphocytic leukaemia, except that lymphocytes are not increased in the peripheral blood; lymph nodes are enlarged and other lymphoid tissue or bone marrow is infiltrated by small lymphocytes.
Synonym: small lymphocytic lymphoma.
(05 Mar 2000)
nodular histiocytic lymphoma <tumour> A B-cell lymphoma with nodular or diffuse lymph node or bone marrow involvement by large lymphoid cells.
Synonym: follicular predominantly small cleaved cell lymphoma, nodular histiocytic lymphoma.
(05 Mar 2000)
nodular lymphoma <tumour> A malignant lymphoma arising from lymphoid follicular B-cells which may be small or large, growing in a nodular pattern.
Synonym: follicular lymphoma, giant follicular lymphoblastoma.
(05 Mar 2000)
non-Hodgkin's lymphoma <oncology, tumour> A group of lymphomas which differ in important ways from Hodgkin's disease and are classified according to the microscopic appearance of the cancer cells. The disease is classified as either low grade (slowly growing), intermediate grade or high grade (rapidly growing) and may be treated in a variety of ways depending on the exact diagnosis. Previously called lymphosarcoma.
(30 Sep 1997)
diffuse small cleaved cell lymphoma <tumour> A diffuse poorly differentiated lymphocytic lymphoma; follicular centre cell lymphoma that lacks a follicular pattern; malignancy is of intermediate grade.
(05 Mar 2000)
immunoblastic lymphoma <tumour> A monomorphous proliferation of immunoblasts involving the lymph nodes; it may develop in some patients with angioimmunoblastic lymphadenopathy.
(05 Mar 2000)
T-cell lymphoma A cancer of the immune system that appears in the skin; also called mycosis fungoides.
(12 Dec 1998)
T-cell-rich, B-cell lymphoma <tumour> A B-cell lymphoma in which more than 90% of the cells are of T-cell origin, masking the large cells that form the neoplastic B-cell component.
See: adult T-cell lymphoma.
(05 Mar 2000)
extra nodal lymphoma <oncology, tumour> Literally outside the lymph nodes, but exhibiting the characteristics of lymph node cancer. A term used to describe the extent and site of disease.
(27 Sep 1997)
Ki-1+ lymphoma <tumour> A form of lymphoma characterised by anaplasia of cells, sinusoidal growth, and immunoreactivity with CD30 (Ki-1 or Ber-H2).
Synonym: Ki-1+ lymphoma.
(05 Mar 2000)
follicular lymphoma <tumour> A malignant lymphoma arising from lymphoid follicular B-cells which may be small or large, growing in a nodular pattern.
Synonym: follicular lymphoma, giant follicular lymphoblastoma.
(05 Mar 2000)
follicular predominantly large cell lymphoma <tumour> A B-cell lymphoma of intermediate malignancy.
(05 Mar 2000)
follicular predominantly small cleaved cell lymphoma <tumour> A B-cell lymphoma with nodular or diffuse lymph node or bone marrow involvement by large lymphoid cells.
Synonym: follicular predominantly small cleaved cell lymphoma, nodular histiocytic lymphoma.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á